Sino Biopharmaceutical | 1177 - Interest Expense On Debt


Sino Biopharmaceutical reported CNY76.87M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Akebia Therapeutics 342.13M 7.53M Sep/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
IQVIA Holdings USD 203M 6M Sep/2026
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Moderna USD 10.96B 527M Jun/2026
Organon & Co USD 106M 2M Sep/2026
Revvity USD 20.81M 2.18M Sep/2026
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Viatris USD 112.4M 8.3M Sep/2026
Xeris Pharmaceuticals USD 6.95M 63K Jun/2026